Article Data

  • Views 282
  • Dowloads 159

Original Research

Open Access

One year health-related quality of life after discharge: a prospective cohort study among COVID-19 ICU survivors

  • Valery Likhvantsev1,2
  • Giovanni Landoni3,4,*,
  • Artem Kuzovlev1
  • Sergey Perekhodov5
  • Nikolay Chaus5
  • Maddalena Tucci4
  • Mary Ann Belli4
  • Kristina Kadantseva1,6
  • Lubov Ermokhina1,5
  • Mikhail Yadgarov1
  • Levan Berikashvili1
  • Valery Subbotin6
  • Nataly Melnikova5
  • Andrey Grechko1

1Department of clinical trials, Federal Scientific and Clinical Center of Reanimatology and Rehabilitation, 107031 Moscow, Russia

2Department of Anesthesia and Intensive Care, First Moscow State Medical University, 119991 Moscow, Russia

3Faculty of Medicine, Vita-Salute San Raffaele University, 20132 Milan, Italy

4Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy

5Department of Anesthesia and Intensive Care, V. Demikhov Municipal Hospital No.68, 109263 Moscow, Russia

6Department of Anesthesia and Intensive Care, A. Loginov Moscow Clinical Scientific Center, 111123 Moscow, Russia

DOI: 10.22514/sv.2022.036

Submitted: 10 February 2022 Accepted: 23 March 2022

Online publish date: 11 May 2022

*Corresponding Author(s): Giovanni Landoni E-mail: landoni.giovanni@hsr.it

Abstract

Considering the paucity of data on long-term Health-Related Quality of Life (HRQoL) in coronavirus disease 2019 (COVID-19) intensive care unit (ICU) survivors, we present one-year follow-up results on patients’ HRQoL and compare them with those of the already reported 6-month follow-up. We conducted a prospective cohort study of patients in COVID-19 ICU between March and June 2020. A HRQoL analysis was performed six months and 1 year after discharge by means of a short-form-36 (SF-36) questionnaire. Hospital mortality in 403 ICU COVID-19 patients was 44.9%; further 4.0% died between hospital discharge and 6-month follow-up and only 0.5% died in the next six months. The median physical component of HRQoL increased from 43.7 (interquartile range (IQR): 31.7–52.7) at 6 months to 46.0 (IQR: 38.0–53.0) 1 year after hospital discharge (p = 0.007). In multivariable regression analysis, age >50 (odds ratio (OR) 0.270) and female sex (OR 0.144) were independently associated with reduced physical HRQoL 1 year after discharge. The median mental component of HRQoL increased from 50.6 (IQR: 42.0–55.8) at 6 months to 53.0 (IQR: 47.0–56.0) 1 year after discharge (p = 0.035), with no significant predictors. Increased HRQoL was associated with an improvement in patients’ physical status, role functioning, emotional well-being (all p < 0.001) and social functioning (p = 0.007). ICU COVID-19 patients’ HRQoL slightly improved 1 year after discharge, when compared to results of the 6-month follow-up. Medications received during ICU stay had no effect on physical or mental HRQoL.


Keywords

COVID-19 survivors; Quality of life; SARS-CoV-2; SF-36 scale; Long-term outcome; Intensive care


Cite and Share

Valery Likhvantsev,Giovanni Landoni,Artem Kuzovlev,Sergey Perekhodov,Nikolay Chaus,Maddalena Tucci,Mary Ann Belli,Kristina Kadantseva,Lubov Ermokhina,Mikhail Yadgarov,Levan Berikashvili,Valery Subbotin,Nataly Melnikova,Andrey Grechko. One year health-related quality of life after discharge: a prospective cohort study among COVID-19 ICU survivors. Signa Vitae. 2022.doi:10.22514/sv.2022.036.

References

[1] Jaffri A, Jaffri UA. Post-intensive care syndrome and COVID-19: crisis after a crisis? Heart & Lung. 2020; 49: 883–884.

[2] Colbenson GA, Johnson A, Wilson ME. Post-intensive care syndrome: impact, prevention, and management. Breathe. 2019; 15: 98–101.

[3] Stollings JL, Caylor MM. Postintensive care syndrome and the role of a follow-up clinic. American Journal of Health-System Pharmacy. 2015; 72: 1315–1323.

[4] Jackson JC, Pandharipande PP, Girard TD, Brummel NE, Thompson JL, Hughes CG, et al. Depression, post-traumatic stress disorder, and functional disability in survivors of critical illness in the BRAIN-ICU study: a longitudinal cohort study. The Lancet Respiratory Medicine. 2014; 2: 369–379.

[5] Sasannejad C, Ely EW, Lahiri S. Long-term cognitive impairment after acute respiratory distress syndrome: a review of clinical impact and pathophysiological mechanisms. Critical Care. 2019; 23: 352.

[6] Gayat E, Cariou A, Deye N, Vieillard-Baron A, Jaber S, Damoisel C, et al. Determinants of long-term outcome in ICU survivors: results from the FROG-ICU study. Critical Care 2018; 22: 8.

[7] Carfì A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020; 324: 603–605.

[8] Huang Y, Tan C, Wu J, Chen M, Wang Z, Luo L, et al. Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase. Respiratory Research. 2020; 21: 163.

[9] Zhao Y, Shang Y, Song W, Li Q, Xie H, Xu Q, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. eClinicalMedicine. 2020; 25: 100463.

[10] Trinkmann F, Müller M, Reif A, Kahn N, Kreuter M, Trudzinski F, et al. Residual symptoms and lower lung function in patients recovering from SARS-CoV-2 infection. European Respiratory Journal. 2021; 57: 2003002.

[11] Tessitore E, Handgraaf S, Poncet A, Achard M, Höfer S, Carballo S, et al. Symptoms and quality of life at 1-year follow up of patients discharged after an acute COVID-19 episode. Swiss Medical Weekly. 2021; 151: w30093.

[12] Wu X, Liu X, Zhou Y, Yu H, Li R, Zhan Q, et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19- related hospitalisation: a prospective study. The Lancet Respiratory Medicine. 2021; 9: 747–754.

[13] Yan X, Huang H, Wang C, Jin Z, Zhang Z, He J, et al. Follow-up study of pulmonary function among COVID-19 survivors 1 year after recovery. Journal of Infection. 2021; 83: 381–412.

[14] Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet. 2021; 397: 220–232.

[15] Huang L, Yao Q, Gu X, Wang Q, Ren L, Wang Y, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. The Lancet. 2021; 398: 747–758.

[16] Likhvantsev V, Landoni G, Perekhodov S, Chaus N, Kadantseva K, Ermokhina L, et al. Six-month quality of life in COVID-19 intensive care unit survivors. To be published in Journal of Cardiothoracic and Vascular Anesthesia. 2021. [Preprint].

[17] Jenkinson C. The SF-36 physical and mental health summary measures: an example of how to interpret scores. Journal of Health Services Research & Policy. 1998; 3: 92–96.

[18] Royal College of Physicians. National early warning score (NEWS): standardising the assessment of acute-illness severity in the NHS. 2021. Available at: https://www.rcplondon.ac.uk/projects/outputs/national-early-warning-score-news-2 (Accessed: 9 September 2021).

[19] Smith GB, Redfern OC, Pimentel MA, Gerry S, Collins GS, Malycha J, et al. The national early warning score 2 (NEWS2). Clinical Medicine Journal. 2019; 19: 260.

[20] Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of Chronic Diseases. 1987; 40: 373–383.

[21] Ware JE. SF-36 health survey update. Spine. 2000; 25: 3130–3139.

[22] Lins L, Carvalho FM. SF-36 total score as a single measure of health-related quality of life: scoping review. SAGE Open Medicine. 2016; 4: 2050312116671725.

[23] DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988; 44: 837–845.

[24] Aranda J, Oriol I, Martín M, Feria L, Vázquez N, Rhyman N, et al. Long-term impact of COVID-19 associated acute respiratory distress syndrome. Journal of Infection. 2021; 83: 581–588.

[25] Seeßle J, Waterboer T, Hippchen T, Simon J, Kirchner M, Lim A, et al. Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study. Clinical Infectious Diseases. 2021; ciab611.

[26] Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nature Medicine. 2021; 27: 626–631.

[27] Nandasena HMRKG, Pathirathna ML, Atapattu AMMP, Prasanga PTS. Quality of life of COVID 19 patients after discharge: systematic review. PLoS One. 2022; 17: e0263941.

[28] Hajian-Tilaki K, Heidari B, Hajian-Tilaki A. Are gender differences in health-related quality of life attributable to sociodemographic character-istics and chronic disease conditions in elderly people? International Journal of Preventive Medicine. 2017; 8: 95.

[29] Pan F, Yang L, Liang B, Ye T, Li L, Li L, et al. Chest CT patterns from diagnosis to 1 year of follow-up in patients with COVID-19. Radiology. 2022: 302: 709–719.

[30] Zangrillo A, Belletti A, Palumbo D, Calvi MR, Guzzo F, Fominskiy EV, et al. One-year multidisciplinary follow-up of patients with COVID-19 requiring invasive mechanical ventilation. Journal of Cardiothoracic and Vascular Anesthesia. 2022; 36: 1354–1363.


Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

IndexCopernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 0.5(2019) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time

Conferences

Top